COVID-19住院后残余肺部异常:UKILD post-COVID-19研究中期分析
该研究基于PHOSP-COVID-19队列,对出院后240天内完成胸部CT的209例患者分析,发现79.4%存在超过10%的残余肺部异常。在其余3491例中,中至极高风险者占7.8%,估计出院后患病率为8.5%(95%CrI 7.6-9.5),敏感性分析升至11.7%(95%CrI 10.3-13.1)。结论认为多达11%的COVID-19住院出院者存在残余肺部异常,应监测高危个体。
要点
- COVID-19住院出院后多达11%的患者存在残余肺部异常。
- 胸部X线异常、DLCO低于80%预计值、需通气支持为危险因素。
- 建议对高危个体进行监测以明确长期功能影响。
核心结论
- COVID-19住院出院后残余肺部异常估计高达11%。
- 卫生服务应监测高危个体以阐明长期功能影响。
研究设计与样本
- 基于PHOSP-COVID-19队列的中期分析,捕获出院后240天内常规及研究随访。
- 通过PHOSP-COVID-19标识链接胸部CT,评估残余肺部异常百分比。
- 采用贝叶斯二项回归估计危险因素并生成风险分层。
- interim队列共3700人,其中209例有链接CT(中位119天,IQR 83-155)。
主要发现
- 209例有链接CT者中166例(79.4%)残余肺部异常累及超过10%。
- 危险因素包括胸部X线异常(RR 1.21,95%CrI 1.05-1.40)。
- DLCO低于80%预计值(RR 1.25,95%CrI 1.00-1.56)和需通气支持的严重入院(RR 1.27,95%CrI 1.07-1.55)也是危险因素。
- 其余3491人中,中至极高风险占7.8%,出院后患病率估计为8.5%(95%CrI 7.6-9.5)。
- 敏感性分析中出院后患病率升至11.7%(95%CrI 10.3-13.1)。
临床怎么用
- 对COVID-19住院出院者,尤其胸部X线异常、DLCO低于80%预计值或需通气支持者,应监测残余肺部异常。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Shared symptoms and genetic architecture between coronavirus disease (COVID-19) and lung fibrosis suggest severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may lead to progressive lung damage. Objectives: The UK Interstitial Lung Disease Consortium (UKILD) post-COVID-19 study interim analysis was planned to estimate the prevalence of residual lung abnormalities in people hospitalized with COVID-19 on the basis of risk strata. Methods: The PHOSP-COVID-19 (Post-Hospitalization COVID-19) study was used to capture routine and research follow-up within 240 days from discharge. Thoracic computed tomography linked by PHOSP-COVID-19 identifiers was scored for the percentage of residual lung abnormalities (ground-glass opacities and reticulations). Risk factors in linked computed tomography were estimated with Bayesian binomial regression, and risk strata were generated. Numbers within strata were used to estimate posthospitalization prevalence using Bayesian binomial distributions. Sensitivity analysis was restricted to participants with protocol-driven research follow-up. Measurements and Main Results: The interim cohort comprised 3,700 people. Of 209 subjects with linked computed tomography (median, 119 d; interquartile range, 83-155), 166 people (79.4%) had more than 10% involvement of residual lung abnormalities. Risk factors included abnormal chest X-ray (risk ratio [RR], 1.21; 95% credible interval [CrI], 1.05-1.40), percent predicted DlCO less than 80% (RR, 1.25; 95% CrI, 1.00-1.56), and severe admission requiring ventilation support (RR, 1.27; 95% CrI, 1.07-1.55). In the remaining 3,491 people, moderate to very high risk of residual lung abnormalities was classified at 7.8%, and posthospitalization prevalence was estimated at 8.5% (95% CrI, 7.6-9.5), rising to 11.7% (95% CrI, 10.3-13.1) in the sensitivity analysis. Conclusions: Residual lung abnormalities were estimated in up to 11% of people discharged after COVID-19-related hospitalization. Health services should monitor at-risk individuals to elucidate long-term functional implications.
引用
- Stewart I, Jacob J, George PM, et al. Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post-COVID-19 Study. Am J Respir Crit Care Med. 2023. PMID: 36457159. doi:10.1164/rccm.202203-0564OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。